Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Gen-Probe; Bio-Rad Laboratories; Becton Dickinson; Genewiz

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe disclosed in a quarterly filing with the US Securities and Exchange Commission this week that it had purchased around $4 million of Roka Bioscience's Series C preferred stock as part of Roka's recently completed $20 million financing round. Roka is a spinout of Gen-Probe to develop molecular assays for biopharmaceutical production, water and food safety testing, and other applications. Gen-Probe said in the filing that it now owns roughly 19 percent of Roka's stock on a fully diluted basis.


Bio-Rad Laboratories was sued this week by South Korean firm NanoEnTek and its subsidiary Digital-Bio Technology for allegedly infringing their US Patent No. 7,842,157, titled, "Method for Bonding Plastic Micro Chip." According to the complaint, filed in the US District Court for the Eastern District of Virginia, the plaintiffs allege that Bio-Rad's TC10 Automated Cell Counter and TC10 Counting Slides infringe their patent.


Becton Dickinson disclosed in a filing with the US Securities and Exchange Commission this week that it paid approximately $205 million for the acquisition of Accuri Cytometers in March.


Genewiz said this week that it has received Quality Management System certification from the International Organization for Standardization for its Suzhou, China operation. The firm provides DNA sequencing, gene synthesis, and other molecular biology services.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more